Stealth Biotech Rally With Momentum Rising…Update-1
Update-1...FED Goes on Hold with Rate Increase Likely by Year End Three on FOMC dissented wanting a rate hike this round. Market immediately rallied with NASDAQ up 1.03% at close; S&P and Dow also rally. Biotechs like low i rates:IBB up 0.62% to $297, XBI up 1.14% to $68.28 highest level...
Biopharma Stocks Show Resilience in Yo-Yo Week…Update-1
Biopharma Stocks Breeze through 'Quadruple Witching Day"...9/16 Healthcare stocks (XLV) were one of the leading sectors on a down day up a tiny bit to $72. The IBB held, up 0.57% to the $291 mark and up 4.75% for the week. The more volatile XBI was a tad weaker down 0.3% on the day. Large caps...
FED Fear Factor Fades then Biotechs Rally: AMGN,IBB…Update-1 Bearish Reversal
Update-1... 9/13... Hard to Call Next Move: Macro and i Rates Rule The market was rattled at the opening with the IEA news on cuts in the demand forecast for crude which dropped 2.33%. Subsequently FED hike fears returned causing more volatility with stocks and significantly a major move up in...
Biotechs Eke Out Gains On Product Pipeline News…Update-2
Update-2...Market rallies Monday after 2% sell-off on Friday IBB held support at $280, up 1.9% today to 284 as of mid-morning . Mid-caps and large caps strong. ------ Update-1... FED Rate Increase Fear Sparks Sell-Off NASDAQ down 1.14%, 10 Year Bond 1.67%, IBB down 1.4%, XBI down 1.64%... 11:30...
Deal of the Day: Cepheid (CPHD) Sells Out to Danaher (DHR) for $4B
M&A Deal of the Day: Cepheid (CPHD) up 50% Over Friday Close on Cash Buyout We have been spending too much time on biopharma. It is time to dust off our Dx and Tools portfolio, which is on hold, and find some value stocks for Q4 moves. We did an update in Q4 of 2015 on Molecular Diagnostics...